Original Article

You have full text access to this OnlineOpen article

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals†‡

  1. Alina Burgi M.P.H.1,
  2. Stephanie Brodine M.D.1,
  3. Scott Wegner M.D.2,3,
  4. Mark Milazzo2,3,
  5. Mark R. Wallace M.D.3,4,
  6. Katherine Spooner M.D.3,5,
  7. David L. Blazes M.D., M.P.H.3,6,
  8. Brian K. Agan M.D.3,7,
  9. Adam Armstrong D.O.3,8,
  10. Susan Fraser M.D.3,9,
  11. Nancy F. Crum M.D., M.P.H.3,4,§,*

Article first published online: 15 AUG 2005

DOI: 10.1002/cncr.21334

Issue

Cancer

Cancer

Volume 104, Issue 7, pages 1505–1511, 1 October 2005

Additional Information

How to Cite

Burgi, A., Brodine, S., Wegner, S., Milazzo, M., Wallace, M. R., Spooner, K., Blazes, D. L., Agan, B. K., Armstrong, A., Fraser, S. and Crum, N. F. (2005), Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer, 104: 1505–1511. doi: 10.1002/cncr.21334

Author Information

  1. 1

    Graduate School of Public Health, San Diego State University, San Diego, California

  2. 2

    United States Military HIV Research Program, Rockville, Maryland

  3. 3

    Tri-Service AIDS Clinical Consortium, Rockville, Maryland

  4. 4

    Infectious Diseases Division, Naval Medical Center, San Diego, California

  5. 5

    Infectious Diseases Division, Walter Reed Army Medical Center, Washington, DC

  6. 6

    Infectious Diseases Division, National Naval Medical Center, Bethesda, Maryland

  7. 7

    Infectious Diseases Division, Wilford Hall United States Air Force Medical Center, Lackland Air Force Base, Texas

  8. 8

    Infectious Diseases Division, Naval Medical Center Portsmouth, Portsmouth, Virginia

  9. 9

    Infectious Diseases Division, Tripler Army Medical Center, Honolulu, Hawaii

  1. §

    Fax: (619) 532-8137

*c/o Clinical Investigation Department (KCA), Naval Medical Center San Diego, 34800 Bob Wilson Drive, Suite 5, San Diego, CA 92134-1005

  1. †

    This is a U.S. government work and, as such, is in the public domain in the United States of America.

  2. ‡

    Presented in condensed form as abstract 886 at the 42nd Annual Meeting of the Infectious Diseases Society of America, Boston, Massachusetts, September 30–October 3, 2004.

Publication History

  1. Issue published online: 17 SEP 2005
  2. Article first published online: 15 AUG 2005
  3. Manuscript Accepted: 11 MAY 2005
  4. Manuscript Received: 26 APR 2005

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (88K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    L. G. Sambo, J. M. Dangou, C. Adebamowo, C. F. Albrecht, C. Gombé-Mbalawa, T. Ngoma, M. Moeti, B. H. Sambo, Cancer in Africa: a preventable public health crisis, Journal Africain du Cancer / African Journal of Cancer, 2012, 4, 2, 127

    CrossRef

  2. 2
    Ricardo Ney Oliveira Cobucci, Humberto Saconato, Paulo Henrique Lima, Hugo Marcus Rodrigues, Tardelli Lapaz Prudêncio, José Eleutério Junior, Paulo César Giraldo, Ana Katherine da Silveira Gonçalves, Comparative incidence of cancer in HIV-AIDS patients and transplant recipients, Cancer Epidemiology, 2012, 36, 2, e69

    CrossRef

  3. 3
    Alfred P See, Jing Zeng, Phuoc T Tran, Michael Lim, Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series, Radiation Oncology, 2011, 6, 1, 25

    CrossRef

  4. 4
    K. H. Tijani, F. O. Adetayo, A. S. Akanmu, C. C. Anunobi, B. O. Mofikoya, E. A. Jeje, Adult squamous cell carcinoma of the scrotum in HIV positive patients in Nigeria, African Journal of Urology, 2011, 16, 2, 49

    CrossRef

  5. 5
    Mark Lazarus, Howard Kaufman, An association between corticosteroid use and melanoma recurrence: a case report and review of the literature, Medical Oncology, 2011,

    CrossRef

  6. 6
    Valeria I Fink, Bryan E Shepherd, Carina Cesar, Alejandro Krolewiecki, Firas Wehbe, Claudia P Cortés, Brenda Crabtree- Ramírez, Denis Padgett, Maryam Shafaee, Mauro Schechter, Eduardo Gotuzzo, Melanie Bacon, Catherine McGowan, Pedro Cahn, Daniel Masys, Cancer in HIV-Infected Persons From the Caribbean, Central and South America, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2011, 56, 5, 467

    CrossRef

  7. 7
    Pere Domingo, Francesc Vidal, Combination antiretroviral therapy, Expert Opinion on Pharmacotherapy, 2011, 12, 7, 995

    CrossRef

  8. 8
    Tanja Mesti, Tanja Južnič Šetina, Marjeta Vovk, Barbara Jezeršek Novaković, Eleven years of experience with AIDS-related lymphomas at the Institute of Oncology Ljubljana, Medical Oncology, 2011, 29, 2, 1217

    CrossRef

  9. 9
    Supriya Krishnan, Jeffrey T. Schouten, Denise L. Jacobson, Constance A. Benson, Ann C. Collier, Susan L. Koletar, Jorge Santana, Fred R. Sattler, Ronald Mitsuyasu, Incidence of Non-AIDS-Defining Cancer in Antiretroviral Treatment-Naïve Subjects after Antiretroviral Treatment Initiation: An ACTG Longitudinal Linked Randomized Trials Analysis, Oncology, 2011, 80, 1-2, 42

    CrossRef

  10. 10
    Chad J Achenbach, Stephen R Cole, Mari M Kitahata, Corey Casper, James H Willig, Michael J Mugavero, Michael S Saag, Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy, AIDS, 2011, 25, 5, 691

    CrossRef

  11. 11
    Eric C. Seaberg, Dorothy Wiley, Otoniel Martínez-Maza, Joan S. Chmiel, Lawrence Kingsley, Yiwei Tang, Joseph B. Margolick, Lisa P. Jacobson, Cancer incidence in the multicenter aids cohort study before and during the HAART era, Cancer, 2010, 116, 23
    Direct Link:
  12. 12
    Gerhard Sissolak, Dagmar Sissolak, Peter Jacobs, Human immunodeficiency and Hodgkin lymphoma, Transfusion and Apheresis Science, 2010, 42, 2, 131

    CrossRef

  13. 13
    Amit C Achhra, Janaki Amin, Matthew G Law, Sean Emery, Jan Gerstoft, Fred M Gordin, Michael J Vjecha, James D Neaton, David A Cooper, Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients, AIDS, 2010, 24, 12, 1877

    CrossRef

  14. 14
    L. Vercellino, V. de Parades, V. Nataf, K. Kerrou, V. Huchet, P. Bauer, O. Pascal, E. Touboul, F. Montravers, J.-N. Talbot, La TEP/TDM au FDG a-t-elle un impact dans la prise en charge des patients atteints d’un cancer du canal anal ?, Médecine Nucléaire, 2010, 34, 2, 96

    CrossRef

  15. 15
    S. Qasmi, C. Sutra-Loubet, E. Maubec, F. Boitier, P. Duvillard, A. Carlotti, E. Marinho, S. Jacobelli, N. Franck, I. Gorin, M.-C. Vacher-Lavenu, F. Bouscarat, B. Crickx, N. Dupin, M.-F. Avril, Mélanomes chez des patients séropositifs pour le VIH : 14 cas, Annales de Dermatologie et de Vénéréologie, 2010, 137, 12, 769

    CrossRef

  16. 16
    Matthew S. Wosnitzer, Franklin C. Lowe, Management of prostate cancer in HIV-positive patients, Nature Reviews Urology, 2010, 7, 6, 348

    CrossRef

  17. 17
    Jacek Kowalski, Grażyna Cholewińska, Non-AIDS-defining cancers among HIV-infected individuals in the highly active antiretroviral therapy era. Case report, HIV & AIDS Review, 2010, 9, 1, 17

    CrossRef

  18. 18
    Minh Ly Nguyen, Kevin James Farrell, Clifford James Gunthel, Non–AIDS-Defining Malignancies in Patients with HIV in the HAART Era, Current Infectious Disease Reports, 2010, 12, 1, 46

    CrossRef

  19. 19
    Joanne Reekie, Csaba Kosa, Frederik Engsig, Antonella d'Arminio Monforte, Alicja Wiercinska-Drapalo, Pere Domingo, Francisco Antunes, Nathan Clumeck, Ole Kirk, Jens D. Lundgren, Amanda Mocroft, Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies, Cancer, 2010, 116, 22
    Direct Link:
  20. 20
    Ayca Gucalp, Ariela Noy, Spectrum of HIV lymphoma 2009, Current Opinion in Hematology, 2010, 17, 4, 362

    CrossRef

  21. 21
    Mary Reed, John M. Cosgrove, Richard Cindrich, Vellore S. Parithivel, Youhanna GAD, Madan Bangalore, Robert Uzor, Jawaid Kalim, Raymundo Segura, Eugene Albu, Ten years later: A single hospital experience with malignancy in HIV/AIDS, Journal of Surgical Oncology, 2010, 102, 3
    Direct Link:
  22. 22
    Susan M. Swetter, Mohammed Kashani-Sabet, Peter Johannet, Sunil A. Reddy, Theodore Locke Phillips, Leibel and Phillips Textbook of Radiation Oncology, 2010,

    CrossRef

  23. 23
    Weedon's Skin Pathology, 2010,

    CrossRef

  24. 24
    David Weedon, Weedon's Skin Pathology, 2010,

    CrossRef

  25. 25
    Meredith S Shiels, Stephen R Cole, Gregory D Kirk, Charles Poole, A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected Individuals, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2009, 52, 5, 611

    CrossRef

  26. 26
    Reinhard Dummer, Maria B Karpova, Marjam J Barysch, Basal cell carcinomas: molecular abnormalities and molecularly targeted therapies, Expert Review of Dermatology, 2009, 4, 4, 355

    CrossRef

  27. 27
    Michael J Silverberg, Donald I Abrams, Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?, Current Opinion in HIV and AIDS, 2009, 4, 1, 42

    CrossRef

  28. 28
    Emilie Lanoy, Graça M Dores, Margaret M Madeleine, Jorge R Toro, Joseph F Fraumeni, Eric A Engels, Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States, AIDS, 2009, 23, 3, 385

    CrossRef

  29. 29
    Liron Pantanowitz, Bruce J Dezube, Evolving spectrum and incidence of non-AIDS-defining malignancies, Current Opinion in HIV and AIDS, 2009, 4, 1, 27

    CrossRef

  30. 30
    John F Deeken, Liron Pantanowitz, Bruce J Dezube, Future treatment for non-AIDS-defining cancers in HIV-infected patients, HIV Therapy, 2009, 3, 4, 311

    CrossRef

  31. 31
    Célia Lloret Linares, Didier Troisvallets, Pierre Sellier, André Aurengo, Laurence Leenhardt, Micrometastasis of papillary thyroid carcinoma in a human immunodeficiency virus-infected patient: a case report and discussion, Medical Oncology, 2009, 27, 3, 756

    CrossRef

  32. 32
    Eric A Engels, Non-0002030-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities, AIDS, 2009, 23, 8, 875

    CrossRef

  33. 33
    Justin Stebbing, Onyinyechi Duru, Mark Bower, Non-AIDS-defining cancers, Current Opinion in Infectious Diseases, 2009, 22, 1, 7

    CrossRef

  34. 34
    Alexander J. Stratigos, Andreas D. Katsambas, The value of screening in melanoma, Clinics in Dermatology, 2009, 27, 1, 10

    CrossRef

  35. 35
    MATTHEW C. UHLENKOTT, SUSAN E. BUSKIN, ERIN M. KAHLE, ELIZABETH BARASH, DAVID M. ABOULAFIA, Causes of Death in the Era of Highly Active Antiretroviral Therapy: A Retrospective Analysis of a Hybrid Hematology-Oncology and HIV Practice and the Seattle/King County Adult/Adolescent Spectrum of HIV-Related Diseases Project, The American Journal of the Medical Sciences, 2008, 336, 3, 217

    CrossRef

  36. 36
    Jason V Baker, Grace Peng, Joshua Rapkin, Donald I Abrams, Michael J Silverberg, Rodger D MacArthur, Winston P Cavert, W Keith Henry, James D Neaton, CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection, AIDS, 2008, 22, 7, 841

    CrossRef

  37. 37
    J Silberstein, T Downs, C Lakin, C J Kane, HIV and prostate cancer: a systematic review of the literature, Prostate Cancer and Prostatic Diseases, 2008, 12, 1, 6

    CrossRef

  38. 38
    HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies, AIDS, 2008, 22, 16, 2143

    CrossRef

  39. 39
    Liron Pantanowitz, Gerry Bohac, Timothy P. Cooley, David Aboulafia, Bruce J. Dezube, Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study, BJU International, 2008, 101, 12
    Direct Link:
  40. 40
    Roger Bedimo, Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era, Current HIV/AIDS Reports, 2008, 5, 3, 140

    CrossRef

  41. 41
    Tracy Ng, Nicholas F. Stein, Jed Kaminetsky, Steven Berman, Hillel Y. Marans, Bill McDermott, Anthony M. Berson, Preliminary Results of Radiation Therapy for Prostate Cancer in Human Immunodeficiency Virus–Positive Patients, Urology, 2008, 72, 5, 1135

    CrossRef

  42. 42
    Constance M. Johnson, Derek Smolenski, Risk assessment models to estimate cancer probabilities, Current Oncology Reports, 2008, 9, 6, 503

    CrossRef

  43. 43
    Kavita P. Bhavan, Vinay N. Kampalath, Edgar Turner Overton, The aging of the HIV epidemic, Current HIV/AIDS Reports, 2008, 5, 3, 150

    CrossRef

  44. 44
    Shilpa Patel, Elisa Weiss, Rosy Chhabra, Laura Ryniker, Roberto Adsuar, Jason Carness, Wendy Kahalas, Carol DeLaMarter, Ira S. Feldman, Judy P. Delorenzo, Ellen Tanner, Bruce Rapkin, The Events in Care Screening Questionnaire (ECSQ): A New Tool to Identify Needs and Concerns of People with HIV/AIDS, AIDS Patient Care and STDs, 2008, 22, 5, 381

    CrossRef

  45. 45
    Lara Stein, Margaret I. Urban, Dianne O'Connell, Xue Qin Yu, Valerie Beral, Rob Newton, Paul Ruff, Bernard Donde, Martin Hale, Moosa Patel, Freddy Sitas, The spectrum of human immunodeficiency virus-associated cancers in a South African black population: Results from a case–control study, 1995–2004, International Journal of Cancer, 2008, 122, 10
    Direct Link:
  46. 46
    C. Vellozzi, J. T. Brooks, T. J. Bush, L. J. Conley, K. Henry, C. C. J. Carpenter, E. T. Overton, J. Hammer, K. Wood, S. D. Holmberg, The Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN Study), American Journal of Epidemiology, 2008, 169, 5, 642

    CrossRef

  47. 47
    Michael J Silverberg, Donald I Abrams, AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era, Current Opinion in Internal Medicine, 2007, 6, 6, 642

    CrossRef

  48. 48
    Vera P. Luther, Aimee M. Wilkin, HIV Infection in Older Adults, Clinics in Geriatric Medicine, 2007, 23, 3, 567

    CrossRef

  49. 49
    Michael J Silverberg, Jacqueline Neuhaus, Mark Bower, Daniela Gey, Angelos Hatzakis, Keith Henry, Jose Hidalgo, Leonardo Lourtau, James D Neaton, Giuseppe Tambussi, Donald I Abrams, Risk of cancers during interrupted antiretroviral therapy in the SMART study, AIDS, 2007, 21, 14, 1957

    CrossRef

  50. 50
    Aruna Alahari Dhir, Sheela Sawant, Rajesh P. Dikshit, Purvish Parikh, Shyam Srivastava, Rajan Badwe, Sunil Rajadhyaksha, K. A. Dinshaw, Spectrum of HIV/AIDS related cancers in India, Cancer Causes & Control, 2007, 19, 2, 147

    CrossRef

  51. 51
    Nancy F. Crum-Cianflone, Alina Burgi, Cancers Among HIV-infected Persons, Infectious Diseases in Clinical Practice, 2006, 14, 5, 258

    CrossRef

  52. 52
    S.Y. Chan, V. Madan, J.T. Lear, M. Helbert, Highly active antiretroviral therapy-induced regression of basal cell carcinomas in a patient with acquired immunodeficiency and Gorlin syndrome, British Journal of Dermatology, 2006, 155, 5
    Direct Link:
  53. 53
    Kord S. Honda, HIV and Skin Cancer, Dermatologic Clinics, 2006, 24, 4, 521

    CrossRef

  54. 54
    C Nakai-Murakami, M Shimura, M Kinomoto, Y Takizawa, K Tokunaga, T Taguchi, S Hoshino, K Miyagawa, T Sata, H Kurumizaka, A Yuo, Y Ishizaka, HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination, Oncogene, 2006, 26, 4, 477

    CrossRef

  55. 55
    Liron Pantanowitz, Hans P Schlecht, Bruce J Dezube, The growing problem of non-AIDS-defining malignancies in HIV, Current Opinion in Oncology, 2006, 18, 5, 469

    CrossRef

  56. 56
    Mark Bower, Rachel Lewis, Justin Stebbing, AIDS-related cancers, Part I: Kaposi's sarcoma and cervical cancer, Community Oncology, 2005, 2, 6, 507

    CrossRef

  57. 57
    C. B. Bunker, F. Gotch, HIV and the Skin,
    Direct Link:
View Full Article (HTML) Get PDF (88K)